Deuterated sevoflurane as an inhalational anesthetic

Details Deuterated sevoflurane as an inhalational anesthetic Deuterated sevoflurane as an inhalational anesthetic

1995-02-15

1998-08-04

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ether doai

A61V 3108

Patent

active

057894507

ABSTRACT:
Use of D2-sevoflurane is disclosed as an inhalational anesthetic. Deuterated sevoflurane possess all of the desirable qualities of sevoflurane as an anesthetic and is metabolized more slowly thereby reducing potentially toxic inorganic fluoride release. More particularly, the compound fluorodideutero methyl 1,1,1,3,3,3-hexafluoropropyl ether is disclosed as well as a method for synthesis.

REFERENCES:
Holaday et al., Deuteration Reduced Significantly the Biotransformation of Sevoflurane, Am Soc. of Anesthesiologist, Inc. 57:3 Sep. 1982.

Affiliated with

Also associated with

Rating

Deuterated sevoflurane as an inhalational anesthetic does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Deuterated sevoflurane as an inhalational anesthetic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Deuterated sevoflurane as an inhalational anesthetic will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1177725